Paradigm has results from its Phase 2 hay fever trial pending in six weeks.
ACCESS THE FULL PRESENTATION HERE
A home run, by the way, is taking a promising drug candidate from the clinic onto the market
The company said it is preparing to meet with US regulators on plans for a phase III trial of its treatment for victims of stroke, while it wants to expand its ophthalmology study
Paul Rennie talked timeline to clinical trial results with investors.